MUC1 in endometriosis and ovarian cancer

Immunologic Research

Volumn 36, Issue 1-3, 2006, Pages 229-236

  Vlad, Anda M ^a   Diaconu, Iulia ^a   Gantt, Kira R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Immune prevention; Immune therapy; MUC1; Premalignancy; Tumor antigens; Vaccines

Indexed keywords

CANCER VACCINE; CONTRACEPTIVE AGENT; GESTAGEN; GONADORELIN AGONIST; MUCIN 1; TUMOR ANTIGEN;

CANCER IMMUNIZATION; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; CHRONIC INFLAMMATION; DRUG TARGETING; ENDOMETRIOSIS; EXPERIENCE; HUMAN; IMMUNITY; IMMUNOTHERAPY; MEDICAL DECISION MAKING; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY;

EID: 33947163463     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:36:1:229     Document Type: Review

References (36)

1. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al: Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990;265: 15286-15293.
2. Hanisch FG, Muller S: MUC1: the polymorphic appearance of a human mucin. Glycobiology 2000;10: 439-449.
3. Burchell JM, Mungul A, Taylor-Papadimitriou J: O-linked glycosylation in the mammary gland: changes that occur during malignancy. J Mammary Gland Biol Neoplasia 2001;6: 355-364.
4. Beum PV, Singh J, Burdick M, Hollingsworth MA, Cheng PW: Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. J Biol Chem 1999;274: 24641-24648.
5. Barnd DL, Lan MS, Metzgar RS, Finn OJ: Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 1989;86: 7159-7163.
6. Fontenot JD, Mariappan SV, Catasti P, Domenech N, Finn OJ, Gupta G: Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope. J Biomol Struct Dyn 1995;13: 245-260.
7. Dunn GP, Old LJ, Schreiber RD: The three Es of cancer immunoediting. Annu Rev Immunol 2004;22: 329-360.
8. Boman F, Buisine MP, Wacrenier A, Querleu D, Aubert JP, Porchet N: Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study. J Pathol 2001;193: 339-344.
9. Cao Y, Schlag PM, Karsten U: Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation. Virchows Arch 1997;431: 159-166.
10. Cao Y, Karsten U, Otto G, Bannasch P: Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Arch 1999;434: 503-509.
11. Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, Corfield AP: Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut 2000;47: 753-761.
12. Reis CA, David L, Correa P, et al: Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999;59: 1003-1007.
13. Lopez-Ferrer A, Curull V, Barranco C, et al: Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am J Respir Cell Mol Biol 2001;24: 22-29.
14. Jarrard JA, Linnoila RI, Lee H, Steinberg SM, Witschi H, Szabo E: MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res 1998;58: 5582-5589.
15. Copin MC, Devisme L, Buisine MP, et al: From normal respiratory mucosa to epidermoid carcinoma: expression of human mucin genes. Int J Cancer 2000;86: 162-168.
16. Buisine MP, Desreumaux P, Leteurtre E, et al: Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 2001;49: 544-551.
17. Masaki Y, Oka M, Ogura Y, et al: Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. Hepatogastroenterology 1999;46: 2240-2245.
18. Luttges J, Feyerabend B, Buchelt T, Pacena M, Kloppel G: The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 2002;26: 466-471.
19. Kohno N: Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 1999;46: 151-158.
20. Takaishi H, Ohara S, Hotta K, et al: Circulating autoantibodies against purified colonic mucin in ulcerative colitis. J Gastroenterol 2000;35: 20-27.
21. Hinoda Y, Nakagawa N, Nakamura H, et al: Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis. Immunol Lett 1993;35: 163-168.
22. Melin A, Sparen P, Persson I, Bergqvist A: Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006;21: 1237-1242.
23. Prowse AH, Manek S, Varma R, et al: Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int J Cancer 2006;119: 556-562.
24. Vigano P, Somigliana E, Chiodo I, Abbiati A, Vercellini P: Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Hum Reprod Update 2006;12: 77-89.
25. Yoshikawa H, Jimbo H, Okada S, et al: Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 2000;50 (Suppl 1): 11-17.
26. Ogawa S, Kaku T, Amada S, et al: Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 2000;77: 298-304.
27. Ness RB: Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 2003;189: 280-294.
28. Brayman M, Thathiah A, Carson DD: MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2004;2: 4.
29. Schenken RS, Williams RF, Hodgen GD: Experimental endometriosis in monkeys. Ann NY Acad Sci 1991;622: 242-255.
30. Schenken RS, Asch RH: Surgical induction of endometriosis in the rabbit: effects on fertility and concentrations of peritoneal fluid prostaglandins. Fertil Steril 1980;34: 581-587.
31. Awwad JT, Sayegh RA, Tao XJ, Hassan T, Awwad ST, Isaacson K: The SCID mouse: an experimental model for endometriosis. Hum Reprod 1999;14: 3107-3111.
32. Sato N, Tsunoda H, Nishida M, et al: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000;60: 7052-7056.
33. Lesche R, Groszer M, Gao J, et al: Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 2002;32: 148-149.
34. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T: Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 2005;11: 63-70.
35. Vlad AM, Kettel JC, Alajez NM, Carlos CA, Finn OJ: MUC1 immunobiology: from discovery to clinical applications. Adv Immunol 2004;82: 249-293.
36. Vlad AM, Muller S, Cudic M, et al: Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells. J Exp Med 2002;196: 1435-1446.